4 September 2025

Pharmaceuticals

Ianalumab hits phase III milestone in Sjögren’s

4 September 2025

Government Rheumatoid Arthritis

PM marks Arthritis Australia’s 75 years

4 September 2025

Menopause Women

‘Shameful’: hormone tests offer no value

4 September 2025

Osteoarthritis Sport

Noisy knees after ACL surgery not a red flag for early arthritis

4 September 2025

Arthritis Public Health

Australia underestimates arthritis at its peril

4 September 2025

Clinical research Osteoarthritis

Virtual and hybrid rehab stacks up

21 August 2025

Vaccination

Recombinant zoster vaccine effective and safe in adults with SLE

21 August 2025

Rheumatoid Arthritis

JAKis linked to Hep B reactivation risk in RA patients

21 August 2025

ACR Guidelines

Global experts set framework for VEXAS care

21 August 2025

FDA Fibromyalgia

FDA approves first new fibromyalgia therapy in 16 years

21 August 2025

Clinical research Pain

No solid evidence ketamine eases chronic pain: researchers

21 August 2025

Paediatrics Psoriasis

Oral psoriasis therapy holds up in kids

7 August 2025

Hidradenitis Suppurativa Mental Health

HS patients face elevated mental health risk

7 August 2025

Biosimilars PBAC

Biosimilars denosumab and tocilizumab head to PBAC

7 August 2025

Clinical research Rheumatoid Arthritis

Placebo response higher in RA trials from lower-income countries

7 August 2025

Musculoskeletal Pain

Cognitive therapy rewires back pain for the long haul